These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 2671547)

  • 21. Comparative leprosy vaccine trial in south India.
    Gupte MD; Vallishayee RS; Anantharaman DS; Nagaraju B; Sreevatsa ; Balasubramanyam S; de Britto RL; Elango N; Uthayakumaran N; Mahalingam VN; Lourdusamy G; Ramalingam A; Kannan S; Arokiasamy J
    Indian J Lepr; 1998; 70(4):369-88. PubMed ID: 10189587
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparative studies on the immunizing effect of BCG, heat-killed tubercle bacilli (Tb 1), a native tubercle bacterial extract and the tuberculin mother substance (TMS) in experimental guinea pig tuberculosis].
    Siefert G
    Arb Paul Ehrlich Inst Georg Speyer Haus Ferdinand Blum Inst Frankf A M; 1966; 62():20-6. PubMed ID: 5952860
    [No Abstract]   [Full Text] [Related]  

  • 23. ILEP organisations should strive for high BCG coverage in communities at risk of leprosy.
    Velema JP; Ogbeiwi OI
    Lepr Rev; 2007 Jun; 78(2):88-101. PubMed ID: 17824479
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [On some experimental aspects of antituberculosis vaccination with BCG].
    Di Perna A; Ciaccia A; Rabinovici A
    Lotta Tuberc; 1967; 37(3):Suppl:187-203. PubMed ID: 5252289
    [No Abstract]   [Full Text] [Related]  

  • 25. [Tuberculosis prevention by BCG vaccine].
    Hashimoto T
    Kekkaku; 1982 Jun; 57(6):329-34. PubMed ID: 6757514
    [No Abstract]   [Full Text] [Related]  

  • 26. Summary of recent abstracts. 8. Leprosy.
    Browne SG
    Trop Dis Bull; 1970 Sep; 67(9):1065-73. PubMed ID: 4321145
    [No Abstract]   [Full Text] [Related]  

  • 27. [Protective efficacy of BCG Tokyo 172 in the guinea pig model of pulmonary tuberculosis].
    Yamamoto T; Phalen S; Uchida K; Umemori K; Nojima Y; Horiuchi Y; Goto Y; McMurray DN; Yamamoto S
    Kekkaku; 2000 May; 75(5):379-88. PubMed ID: 10853313
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Scar size and effectiveness of Bacillus Calmette Guerin (BCG) vaccination in the prevention of tuberculosis and leprosy: a case-control study.
    Zodpey SP; Shrikhande SN; Kulkarni SW; Maldhure BR
    Indian J Public Health; 2007; 51(3):184-9. PubMed ID: 18229442
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tuberculosis prevention: where do we go from here?
    Warndorff DK
    Afr Health; 1996 Nov; 19(1):21-2. PubMed ID: 12291917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new attenuated Mycobacterium bovis vaccine protects brushtail possums (Trichosurus vulpecula) against experimental tuberculosis infection.
    Collins DM; de Lisle GW; Aldwell FE; Buddle BM
    Vaccine; 2007 Jun; 25(24):4659-64. PubMed ID: 17498852
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decreased survival of guinea pigs infected with Mycobacterium tuberculosis after multiple BCG vaccinations.
    Basaraba RJ; Izzo AA; Brandt L; Orme IM
    Vaccine; 2006 Jan; 24(3):280-6. PubMed ID: 16153758
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tuberculin reactivity and tuberculosis epidemiology in the Pakaanóva (Wari') Indians of Rondônia, south-western Brazilian Amazon.
    Escobar AL; Coimbra CE; Camacho LA; Santos RV
    Int J Tuberc Lung Dis; 2004 Jan; 8(1):45-51. PubMed ID: 14974745
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the protective efficacy of bacille calmette-Guérin vaccination against aerosol challenge with Mycobacterium tuberculosis and Mycobacterium bovis.
    Williams A; Davies A; Marsh PD; Chambers MA; Hewinson RG
    Clin Infect Dis; 2000 Jun; 30 Suppl 3():S299-301. PubMed ID: 10875804
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Experimental study of BCG-M vaccine with a lowered antigen dose].
    Iablokova TB; Pisarenko NN; Levi DT; Kazachkova TE; Nesterenko LA
    Probl Tuberk; 1985; (6):52-5. PubMed ID: 3900992
    [No Abstract]   [Full Text] [Related]  

  • 35. The BCG controversy: a reappraisal of the protective effect against tuberculosis and leprosy.
    Zodpey SP
    Indian J Public Health; 2004; 48(2):70-7. PubMed ID: 15709589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intranasal bacille Calmette-Guerin (BCG) vaccine dosage needs balancing between protection and lung pathology.
    Tree JA; Williams A; Clark S; Hall G; Marsh PD; Ivanyi J
    Clin Exp Immunol; 2004 Dec; 138(3):405-9. PubMed ID: 15544615
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protective effect of BCG in experimental tuberculosis.
    Smith DW
    Adv Tuberc Res; 1985; 22():1-97. PubMed ID: 3909787
    [No Abstract]   [Full Text] [Related]  

  • 38. [Search for new tuberculosis vaccines].
    Gicquel B
    Bull Acad Natl Med; 1999; 183(7):53-61; discussion 61-2. PubMed ID: 10622122
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of V.D.S. (diffusible killed antitubercular vaccine Salvioli) on the course of experimental tuberculosis in guinea-pigs evoked by H 37 Rv strain bacilli.
    Fafrowicz B; Szmygin J
    Clin Pediatr (Bologna); 1970 Jul; 52(7):299-302. PubMed ID: 4998498
    [No Abstract]   [Full Text] [Related]  

  • 40. BCG vaccination.
    Ironside AG
    Practitioner; 1971 Apr; 206(234):488-93. PubMed ID: 5576887
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.